1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Global Drug Discovery and Development Analysis & Statistics, December 2016

Global Drug Discovery and Development Analysis & Statistics, December 2016

1-30 of about 1400 reports

Purchase Reports From Reputable Market Research Publishers

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Biotechnology
  • Countries : World, North America
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, Europe, Asia
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

  • $ 4995
  • Industry report
  • October 2016
  • by GBI Research

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth Summary Cardiovascular disease (CVD) covers a range of difference ...

  • Industries : Chronic Disease, Pathology
  • Countries : World
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape

  • $ 4995
  • Industry report
  • September 2016
  • by GBI Research

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Disease and disorders involving ...

  • Industries : Pharmaceutical, Therapy
  • Countries : World
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer vaccines are being ...

  • Industries : Therapy, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy Summary Hemophilia ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : World, Asia
Genome Editing Global Market - Forecast to 2022

Genome Editing Global Market - Forecast to 2022

  • $ 4950
  • Industry report
  • September 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Ever since the establishment of the genetic basis of life, researchers have tried to manipulate genes in plants and animals to improve traits. There has been a continuous evolution of gene modification ...

  • Industries : Biotechnology
  • Countries : World
Global High Throughput Screening (HTS) Industry

Global High Throughput Screening (HTS) Industry

  • $ 4500
  • Industry report
  • October 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million by the following Product Segments: Consumables/Reagents, Instruments, and Software and Services. The report ...

  • Industries : Drug Discovery and Development
  • Countries : United States, World, Europe
Enteric Disease Testing - Global Market Outlook (2016-2022)

Enteric Disease Testing - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Enteric Disease Testing market is expected to grow from $3.86 billion in 2015 to reach $5.12 billion by 2022 with a CAGR of 4.1%. Enteric disease testing market ...

  • Industries : Pathology
  • Countries : World, Asia, Europe, North America
Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

  • Industries : Drug Discovery and Development
  • Countries : World
Drug Discovery Technologies - Global Market Outlook (2016-2022)

Drug Discovery Technologies - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. ...

  • Industries : Drug Discovery and Development
  • Countries : World, Asia, Europe, North America
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology, Chronic Disease
  • Countries : United States, World
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer
  • Countries : World, Spain, United States
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2016

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histamine H4 Recepto ...

  • Industries : Drug Discovery and Development, Pathology, In Vitro Diagnostics, Pharmaceutical, Therapy
  • Countries : World, United Kingdom
Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Eukaryotic Translation Initiation ...

  • Industries : Cancer, Therapy, Biopharmaceutical, Pathology, Drug Discovery and Development
  • Countries : World, United States
Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC 3.2.1.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : Europe, United States, World
Substance K Receptor (NK2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or NK2R or TACR2) - Pipeline Review, H2 2016

Substance K Receptor (NK2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or NK2R or TACR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Substance K Receptor (NK2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or NK2R or TACR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Substance K Receptor (NK2 Recepto ...

  • Industries : Drug Discovery and Development, Therapy, Pharmaceutical
  • Countries : World
Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2016

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : Pathology, Therapy, Drug Discovery and Development, Pharmaceutical, In Vitro Diagnostics
  • Countries : United States, World
Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016

Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila ...

  • Industries : Cancer, Pathology, Therapy, Biopharmaceutical
  • Countries : United States, World
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycogen Synthase Kinase ...

  • Industries : Chronic Disease, Pathology, Pharmaceutical, Drug Discovery and Development, Therapy, Biopharmaceutical
  • Countries : World, United States, Asia
Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2016

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : Biopharmaceutical, Cancer, Drug Discovery and Development, Pathology
  • Countries : World, Canada
Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : World
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - ...

  • Industries : Therapy, Pharmaceutical, Drug Discovery and Development
  • Countries : Australia, World
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) ...

  • Industries : Mental Health, Therapy, Biopharmaceutical, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : United States, World
Global and Chinese High Content Screening Industry, 2016 Market Research Report

Global and Chinese High Content Screening Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese High Content Screening Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global High Content Screening industry with ...

  • Industries : Drug Discovery and Development
  • Countries : World
Global and Chinese Drug Discovery Industry, 2016 Market Research Report

Global and Chinese Drug Discovery Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Drug Discovery Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Drug Discovery industry with a focus on the ...

  • Industries : Drug Discovery and Development
  • Countries : World
Global and Chinese High Throughput Screening (HTS) Industry, 2016 Market Research Report

Global and Chinese High Throughput Screening (HTS) Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese High Throughput Screening (HTS) Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global High Throughput Screening ...

  • Industries : Drug Discovery and Development
  • Countries : World
Global Solid Tumors Drugs Market Research Report 2016

Global Solid Tumors Drugs Market Research Report 2016

  • $ 2850
  • Industry report
  • September 2016
  • by 9Dimen Research

2016 Global Solid Tumors Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Solid Tumors Drugs industry, focusing on the main regions ...

  • Industries : Drug Discovery and Development
  • Countries : World, Europe, Asia, North America
Global Alzheimers Disease Drug Market Research Report 2016

Global Alzheimers Disease Drug Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Alzheimers Disease Drug Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Alzheimers Disease Drug industry, focusing on the ...

  • Industries : Drug Discovery and Development
  • Countries : World, Europe, Asia, North America
Global and Chinese Clinical Trial Management System Industry, 2016 Market Research Report

Global and Chinese Clinical Trial Management System Industry, 2016 Market Research Report

  • $ 2800
  • Industry report
  • November 2016
  • by Prof Research

The 'Global and Chinese Clinical Trial Management System Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Clinical Trial Management System ...

  • Industries : Drug Discovery and Development
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.